234 related articles for article (PubMed ID: 9231890)
1. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.
DeQuattro V; Lee D
Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group.
DeQuattro V; Lee D; Messerli F
Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443
[TBL] [Abstract][Full Text] [Related]
3. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
Messerli F; Frishman WH; Elliott WJ
Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
[TBL] [Abstract][Full Text] [Related]
4. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Muijsers RB; Curran MP; Perry CM
Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
[TBL] [Abstract][Full Text] [Related]
5. The fixed combination of verapamil SR/trandolapril.
Widimský J
Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
[TBL] [Abstract][Full Text] [Related]
6. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
Veratran Study Group
Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
[TBL] [Abstract][Full Text] [Related]
7. Fixed combination verapamil SR/trandolapril.
Dooley M; Goa KL
Drugs; 1998 Nov; 56(5):837-44; discussion 845-6. PubMed ID: 9829157
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists.
Karlberg BE; Andrup M; Odén A
Blood Press; 2000; 9(2-3):140-5. PubMed ID: 10855738
[TBL] [Abstract][Full Text] [Related]
9. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
Scholze J; Zilles P; Compagnone D
Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
[TBL] [Abstract][Full Text] [Related]
10. Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group.
Holzgreve H; Compagnone D; Zilles P
J Hum Hypertens; 1999 Jan; 13(1):61-7. PubMed ID: 9928754
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
[TBL] [Abstract][Full Text] [Related]
12. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Holzgreve H; Nakov R; Beck K; Janka HU
Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy of a once a day verapamil SR/trandolapril combination.
Oren S; Viskoper JR; Zilles P
Int J Cardiol; 1996 Jul; 55(1):97-102. PubMed ID: 8839816
[TBL] [Abstract][Full Text] [Related]
15. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of the combination of verapamil and trandolapril.
Holzgreve H
J Hypertens Suppl; 1997 Mar; 15(2):S51-3. PubMed ID: 9218199
[TBL] [Abstract][Full Text] [Related]
17. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Ruilope LM; Usan L; Segura J; Bakris GL
J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
[TBL] [Abstract][Full Text] [Related]
18. Preventing microalbuminuria in type 2 diabetes.
Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ
Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313
[TBL] [Abstract][Full Text] [Related]
20. Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.
Reynolds NA; Wagstaff AJ; Keam SJ
Drugs; 2005; 65(13):1893-914. PubMed ID: 16114984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
